Recent news on Zeffix

Pharma Sector: Few Newsmakers Of The Week - Idenix, Nabi, CSL ...  -  May 5, 2007
Trading Markets,Gilead Sciences' Hepsera and GlaxoSmithKline's Zeffix are the two main competitors to Tyzeka in the marketplace. Maxim Group analysts estimate the peak

SHIRE PLC - 1st Quarter Results  -  Apr 25, 2007
PR-Inside.com (Pressemitteilung),ZEFFIX - Chronic hepatitis B infection Royalties from sales of ZEFFIX for the three months to March 31, 2007 were $9.1 million, an increase of 18% compared

GSK to export to 70 markets from Poznan  -  Mar 1, 2007
Polish Market,Trizivir and Ziagen) and one used in chronic hepatitis B (Zeffix). Delivery of two of these products to Western and Central Europe began in 2006.

Shire plc: On Time Execution of Operating Plan Delivers Strong ...  -  Feb 20, 2007
Earthtimes.orgRoyalties from sales of ZEFFIX for the year to December 31, 2006 were US$34.8 million, an increase of 14% compared to the prior year (2005: US$30.5 million)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional